Consolidation continues as Catalent lays down $330m for MaSTherCell
Catalent provides another example of the trend by bigger CDMO to snatch up smaller cell and gene therapy specialists.
Archives for February 5, 2020
Aridis’ cell line ‘halves’ mAb manufacturing time
Aiming to facilitate and accelerate discovery of biologics, Aridis’ Apex platform can also discover antibodies against viruses ‘within one day of a pandemic’.
Patient confidence key in switching delivery of biosimilars
As developers of biosimilars look at ways of differentiating from originator products, experts warn that patients will need to be brought on board.
RaniPill passes Phase I test for orally delivered biologics
Rani Therapeutics releases positive results from a Phase I clinical study into delivering octreotide by RaniPill.